A DrugGPT-derived model, fine-tuned on approved drugs and optimized with reinforcement learning, produces more valid molecules and higher purported binding affinities, though the affinity metric is the training reward.
D e novo molecular design and generative models,
1 Pith paper cite this work. Polarity classification is still indexing.
1
Pith paper citing it
fields
q-bio.QM 1years
2024 1verdicts
REJECT 1representative citing papers
citing papers explorer
-
DrugGen: Advancing Drug Discovery with Large Language Models and Reinforcement Learning Feedback
A DrugGPT-derived model, fine-tuned on approved drugs and optimized with reinforcement learning, produces more valid molecules and higher purported binding affinities, though the affinity metric is the training reward.